Which strategy describes “ex vivo” gene therapy?
Show answer and explanation
Correct answer: Modifying the patient's own cells in culture, then re-infusing them
Ex vivo gene therapy removes the patient's cells (e.g. stem or immune cells), modifies them in culture by gene addition or editing, and re-infuses them. It is used in some blood disorders and cancers.
Keep practicing
More Gene therapy basics questions
- Which viral vector type is particularly favored for gene therapy because it typically does not integrate into the host genome, reducing ris…
- What is one major limitation of AAV vectors in gene therapy?
- Which of the following is a potential benefit of gene editing (e.g., using CRISPR) over traditional gene addition therapy?
- What is a major concern associated with genome-editing gene therapy methods like CRISPR in clinical application?
- Which of the following is NOT a major type of gene therapy approach?
- Why is tissue-specific targeting an important consideration when designing gene therapy vectors?